Lite Share Price

Lite Share Price

NASDAQ: LITS | Micro Cap | Financial Services
$0.81
+$0.03 (3.22%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Lite Stock Performance

Open
$0.80
Prev. Close
$0.79
Circuit Range
N/A
Day Range
$0.79 - $0.81
Year Range
$0.69 - $2.00
Volume
6,536
Average Traded
$0.80

Lite Share Price Today

As of 19 November 2026, Lite Strategy, Inc.'s share price is $0.81. The stock opened at $0.80, compared to its previous close of $0.79. During today's trading session, Lite Strategy, Inc.'s share price traded between $0.79 and $0.81, with an average price of $0.80. Over the past 52 weeks, the stock has recorded a high of $2.00 and a low of $0.69. In terms of performance, Lite Strategy, Inc.'s share price has declined by 19.23% over the last six months and is down 57.10% on a year-on-year basis.

Lite Share Price Chart

Line chart of the Lite price trend over the selected period. The price rose overall, ranging from 0.79 to 0.81, ending at 0.81.
$0.79$0.81
L
Show Current Price
H

Lite Stock Fundamentals & Key Indicators

Market Cap
$5.40M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.72
Revenue (TTM)
$0.00
Return On Equity (TTM)
-90.82%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
152.01%

Lite Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$30.80-$23.69-$13.02$16.02
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A23.08%45.04%223.04%

Lite Annual Profit & Loss

All figures in USD

Particulars2026
Revenue$0.00
Net Profit-$71.15
Net Profit MarginN/A
Income ChangeN/A

Lite Balance Sheet

All figures in USD Million

Particulars2026
Non Current Assets36.55
Current Assets6.14
Total Assets42.69
Non Current Liabilities0.0
Current Liabilities1.07
Total Liabilities1.07
Shareholders' Equity41.62

Lite Cash Flow

Annually

All figures in USD Million

Particulars2026
Operating-9.12
Investing-95.11
Financing91.92

About Lite

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.

Lite Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.10
$0.81
-28.00%
Oct 2026
$1.29
$1.13
-14.77%
Sep 2026
$0.98
$1.32
+30.69%
Aug 2026
$0.98
$1.01
+5.87%
Jul 2026
$0.95
$0.95
+2.36%
Jun 2026
$0.97
$0.93
-7.17%
May 2026
$1.15
$1.00
-13.07%
Apr 2026
$1.15
$1.16
+0.87%
Mar 2026
$1.10
$1.15
+0.44%
Feb 2026
$1.21
$1.14
-5.79%
Jan 2026
$1.46
$1.21
-9.70%
Dec 2025
$1.73
$1.34
-29.10%

Lite Share Price FAQs